ENT device cassification
This article was originally published in The Gray Sheet
FDA proposes to classify nasal dilators, intranasal splints and bone particle collectors into Class I and to exempt the devices from 510(k) requirements in a May 11 Federal Register notice. FDA's Ear, Nose, and Throat Devices Advisory Panel recommended placing the devices into Class I during a 1990 panel meeting ("The Gray Sheet" Oct. 29, 1990, p. 8). FDA says it had "inadvertently omitted classifying" these types of devices in 1986 when the agency published a final rule classifying ear, nose, and throat devices. Comments are due by Aug. 10...
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.